Protective efficacy of recombinant (Ag85A) BCG Tokyo with Ag85A peptide boosting against Mycobacterium tuberculosis-infected guinea pigs in comparison with that of DNA vaccine encoding Ag85A. (Q46630257)

From Wikidata

Jump to navigation Jump to search

scientific article published on 30 June 2006

Language	Label	Description	Also known as
English	Protective efficacy of recombinant (Ag85A) BCG Tokyo with Ag85A peptide boosting against Mycobacterium tuberculosis-infected guinea pigs in comparison with that of DNA vaccine encoding Ag85A.	scientific article published on 30 June 2006

Statements

scholarly article

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16815096

Protective efficacy of recombinant (Ag85A) BCG Tokyo with Ag85A peptide boosting against Mycobacterium tuberculosis-infected guinea pigs in comparison with that of DNA vaccine encoding Ag85A. (English)

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16815096

Mycobacterium tuberculosis

1 reference

based on heuristic

inferred from title

author name string

Sugawara I

1

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16815096

Udagawa T

2

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16815096

Taniyama T

3

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16815096

publication date

30 June 2006

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16815096

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16815096

87

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16815096

2

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16815096

94-101

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16815096

Is the development of a new tuberculosis vaccine possible?

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.001

7 January 2021

Beyond BCG: the potential for a more effective TB vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.001

7 January 2021

Immunogenicity and protective efficacy of a tuberculosis DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.001

7 January 2021

Tuberculosis DNA vaccine encoding Ag85A is immunogenic and protective when administered by intramuscular needle injection but not by epidermal gene gun bombardment

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.001

7 January 2021

Vaccination of guinea pigs with DNA encoding the mycobacterial antigen MPB83 influences pulmonary pathology but not hematogenous spread following aerogenic infection with Mycobacterium bovis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.001

7 January 2021

Vaccination of guinea pigs with DNA encoding Ag85A by gene gun bombardment

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.001

7 January 2021

Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.001

7 January 2021

Disruption of nuclear factor-interleukin-6, a transcription factor, results in severe mycobacterial infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.001

7 January 2021

Induction of granulomas in interferon-gamma gene-disrupted mice by avirulent but not by virulent strains of Mycobacterium tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.001

7 January 2021

Relative importance of STAT4 in murine tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.001

7 January 2021

Mapping of murine Th1 helper T-Cell epitopes of mycolyl transferases Ag85A, Ag85B, and Ag85C from Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.001

7 January 2021

Newly designed primer sets available for evaluating various cytokines and iNOS mRNA expression in guinea pig lung tissues by RT-PCR.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.001

7 January 2021

Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.001

7 January 2021

BCG-induced protection in guinea pigs vaccinated and challenged via the respiratory route

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.001

7 January 2021

Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.001

7 January 2021

Improved tuberculosis DNA vaccines by formulation in cationic lipids

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.001

7 January 2021

Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.001

7 January 2021

Pulmonary necrosis resulting from DNA vaccination against tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.001

7 January 2021

Differential immune responses and protective efficacy induced by components of a tuberculosis polyprotein vaccine, Mtb72F, delivered as naked DNA or recombinant protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.001

7 January 2021

The protective effect of the Mycobacterium bovis BCG vaccine is increased by coadministration with the Mycobacterium tuberculosis 72-kilodalton fusion polyprotein Mtb72F in M. tuberculosis-infected guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.001

7 January 2021

Auxotrophic vaccines for tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.001

7 January 2021

Recombinant BCG expressing Mycobacterium tuberculosis major extracellular proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.001

7 January 2021

ESAT-6 subunit vaccination against Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.001

7 January 2021

Pathophysiology of antigen 85 in patients with active tuberculosis: antigen 85 circulates as complexes with fibronectin and immunoglobulin G.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.05.001

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.TUBE.2006.05.001

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16815096

release_fvrei4siufanflnvqxfdq6pdim

1 reference

https://api.fatcat.wiki/v0/release/fvrei4siufanflnvqxfdq6pdim

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16815096

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46630257&oldid=2109433164"